Lycia Therapeutics

1 follower

‌

We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Aetna Wun Trombley

President & CEO

Aetna Wun Trombley

Collapse

Steve Staben

Chief Scientific Officer

Winsome Chung

VP, Finance

Matt Holdren

Vice President, Nonclinical Development

Larry Rozsnyai

Vice President, Intellectual Property

Nadia Tchao

Executive Director, Head of Translational Medicine & Early Development

Darrin Lindhout

Head of Biologics

Patricia Chang

Associate Director, Project And Alliance Management

Teams

+13

Scientific Research Team

16 members

Directors Team

6 members

Research and Development

5 members

Advisory Team

5 members

Leadership Team

2 members

Similar companies

Tessera Therapeutics

2 followers

Septerna

2 followers

89bio

2 followers

Neogene Therapeutics

2 followers

Protein Metrics

2 followers

SolarBioTech

2 followers

MassBio

1 follower

Capricor Therapeutics

1 follower

Abcuro

1 follower

MedRhythms

1 follower

PrognomiQ

1 follower

Explore companies